{"transactions":[{"id":731648,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:32:03.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":30.57,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-26-000260","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645330/000161071726000260/form4.xml","form_type":"4"}},{"id":741679,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:27.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":3.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-072927","document":"tm2617547-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926072927/tm2617547-8_4seq1.xml","form_type":"4"}},{"id":1100801,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T20:54:45.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":21.78,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-25-000261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645330/000161071725000261/form4.xml","form_type":"4"}},{"id":1122864,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T01:03:21.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":3.28,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-25-056564","document":"tm2517191-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925056564/tm2517191-5_4seq1.xml","form_type":"4"}},{"id":1279618,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-02-07T19:39:04.000Z","date":"2025-02-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8147,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents restricted stock units (\"RSUs\") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8147},"source":{"system":"sec-edgar","filing":"0001683168-25-000860","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316825000860/ownership.xml","form_type":"4"}},{"id":1279617,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-07T19:39:04.000Z","date":"2025-02-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10030,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents stock options (\"Options\") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":10.72,"expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":10030},"source":{"system":"sec-edgar","filing":"0001683168-25-000860","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316825000860/ownership.xml","form_type":"4"}},{"id":1279616,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-07T19:39:04.000Z","date":"2025-02-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19675,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents stock options (\"Options\") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."}],"balance_after":10030,"derivative":{"exercise_price":6.87,"expiration_date":"2027-01-09","underlying":"Common Stock","underlying_shares":19675},"source":{"system":"sec-edgar","filing":"0001683168-25-000860","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316825000860/ownership.xml","form_type":"4"}},{"id":1279615,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-07T19:39:04.000Z","date":"2025-02-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32100,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents stock options (\"Options\") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."}],"balance_after":29705,"derivative":{"exercise_price":6.38,"expiration_date":"2026-07-25","underlying":"Common Stock","underlying_shares":32100},"source":{"system":"sec-edgar","filing":"0001683168-25-000860","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316825000860/ownership.xml","form_type":"4"}},{"id":1279614,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2025-02-07T19:39:04.000Z","date":"2025-02-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":43379,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock that were disposed of at the effective time (the \"Effective Time\") of the merger (the \"Merger\") of Space Mergerco, Inc. (\"Merger Sub\") with and into Avid Bioservices, Inc. (the \"Issuer\") pursuant to the Agreement and Plan of Merger, dated as of November 6, 2024 (the \"Merger Agreement\"), by and among the Issuer, Space Finco, Inc., and Merger Sub."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each outstanding share of common stock was cancelled and converted into the right to receive a cash payment per share of $12.50, without interest, subject to the terms and conditions of the Merger Agreement (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001683168-25-000860","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316825000860/ownership.xml","form_type":"4"}},{"id":1329984,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-12-17T19:48:42.000Z","date":"2024-12-14","kind":"grant","planned":false,"acquired":true,"shares":8147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Annual equity award grant pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted to the reporting person on December 14, 2024 shall fully vest on December 14, 2025, subject to the reporting person's continuous service to the Issuer on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted to the reporting person on December 14, 2024 shall fully vest on December 14, 2025, subject to the reporting person's continuous service to the Issuer on such vesting date."}],"balance_after":8147,"derivative":{"underlying":"Common Stock","underlying_shares":8147},"source":{"system":"sec-edgar","filing":"0001683168-24-008803","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316824008803/ownership.xml","form_type":"4"}},{"id":1329983,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-12-17T19:48:42.000Z","date":"2024-12-14","kind":"exercise","planned":false,"acquired":false,"shares":26756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2023 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2023 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26756},"source":{"system":"sec-edgar","filing":"0001683168-24-008803","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316824008803/ownership.xml","form_type":"4"}},{"id":1329982,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2024-12-17T19:48:42.000Z","date":"2024-12-14","kind":"exercise","planned":false,"acquired":true,"shares":26756,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."}],"balance_after":43379,"source":{"system":"sec-edgar","filing":"0001683168-24-008803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316824008803/ownership.xml","form_type":"4"}},{"id":1486739,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:19:25.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":8.7,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-24-069662","document":"tm2416702-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924069662/tm2416702-5_4seq1.xml","form_type":"4"}},{"id":1496297,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T20:30:21.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":16200,"derivative":{"exercise_price":36.55,"expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001610717-24-000273","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645330/000161071724000273/form4.xml","form_type":"4"}},{"id":1708302,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-12-18T19:32:11.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":26756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Annual equity award grant pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted to the reporting person on December 14, 2023 shall fully vest on December 14, 2024, subject to the reporting person's continuous service to the Issuer on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted to the reporting person on December 14, 2023 shall fully vest on December 14, 2024, subject to the reporting person's continuous service to the Issuer on such vesting date."}],"balance_after":26756,"derivative":{"underlying":"Common Stock","underlying_shares":26756},"source":{"system":"sec-edgar","filing":"0001683168-23-008942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316823008942/ownership.xml","form_type":"4"}},{"id":1708301,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-12-18T19:32:11.000Z","date":"2023-12-14","kind":"exercise","planned":false,"acquired":false,"shares":9612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2022 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2022 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9612},"source":{"system":"sec-edgar","filing":"0001683168-23-008942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316823008942/ownership.xml","form_type":"4"}},{"id":1708300,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2023-12-18T19:32:11.000Z","date":"2023-12-14","kind":"exercise","planned":false,"acquired":true,"shares":9612,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."}],"balance_after":16623,"source":{"system":"sec-edgar","filing":"0001683168-23-008942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316823008942/ownership.xml","form_type":"4"}},{"id":1860016,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-09T20:46:39.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":16200,"derivative":{"exercise_price":25.4,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001610717-23-000113","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645330/000161071723000113/form4.xml","form_type":"4"}},{"id":1863873,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-07T20:40:51.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":22000,"derivative":{"exercise_price":12.57,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001104659-23-068932","document":"tm2317994-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465923068932/tm2317994-8_4seq1.xml","form_type":"4"}},{"id":2084525,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-12-16T20:01:21.000Z","date":"2022-12-14","kind":"grant","acquired":true,"shares":9612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Annual equity award grant pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs granted to the reported person on December 14, 2022 shall fully vest on December 14, 2023, subject to the reporting person's continuous service to the Issuer on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs granted to the reported person on December 14, 2022 shall fully vest on December 14, 2023, subject to the reporting person's continuous service to the Issuer on such vesting date."}],"balance_after":9612,"derivative":{"underlying":"Common Stock","underlying_shares":9612},"source":{"system":"sec-edgar","filing":"0001683168-22-008497","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316822008497/ownership.xml","form_type":"4"}},{"id":2084524,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-12-16T20:01:21.000Z","date":"2022-12-14","kind":"exercise","acquired":false,"shares":4632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2021 pursuant to the Issuer's non-employee director compensation program which fully vested on December 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2021 pursuant to the Issuer's non-employee director compensation program which fully vested on December 14, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4632},"source":{"system":"sec-edgar","filing":"0001683168-22-008497","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316822008497/ownership.xml","form_type":"4"}},{"id":2084523,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2022-12-16T20:01:21.000Z","date":"2022-12-14","kind":"exercise","acquired":true,"shares":4632,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."}],"balance_after":7011,"source":{"system":"sec-edgar","filing":"0001683168-22-008497","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316822008497/ownership.xml","form_type":"4"}},{"id":2184235,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-16T21:03:31.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. The option vests over four years, with 1/16th of the shares of common stock underlying the option vesting upon the three-month anniversary of the Vesting Commencement Date and an additional 1/16th of the shares of common stock underlying the option vesting at the end of each successive three-month period thereafter, subject to the Reporting Person's continued service as a director."}],"balance_after":44000,"derivative":{"exercise_price":6.02,"expiration_date":"2032-08-15","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-22-091816","document":"tm2223558-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465922091816/tm2223558-2_4seq1.xml","form_type":"4"}},{"id":2302163,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-06T20:23:01.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from April 5, 2022 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date."}],"balance_after":22000,"derivative":{"exercise_price":11.8,"expiration_date":"2032-04-04","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001567619-22-008194","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645330/000156761922008194/doc1.xml","form_type":"4"}},{"id":2470820,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-12-16T21:33:43.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":4632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Annual equity award grant pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs granted to the reporting person shall fully vest on December 14, 2022, subject to the reporting person's continuous service to the Issuer on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs granted to the reporting person shall fully vest on December 14, 2022, subject to the reporting person's continuous service to the Issuer on such vesting date."}],"balance_after":4632,"derivative":{"underlying":"Common Stock","underlying_shares":4632},"source":{"system":"sec-edgar","filing":"0001683168-21-006438","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316821006438/ownership.xml","form_type":"4"}},{"id":2470819,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-12-16T21:33:43.000Z","date":"2021-12-14","kind":"exercise","acquired":false,"shares":2379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2020 fully vested on December 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2020 fully vested on December 14, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2379},"source":{"system":"sec-edgar","filing":"0001683168-21-006438","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316821006438/ownership.xml","form_type":"4"}},{"id":2470818,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2021-12-16T21:33:43.000Z","date":"2021-12-14","kind":"exercise","acquired":true,"shares":2379,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."}],"balance_after":2379,"source":{"system":"sec-edgar","filing":"0001683168-21-006438","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316821006438/ownership.xml","form_type":"4"}},{"id":2502221,"issuer":{"id":133265,"kind":"organization","name":"Trillium Therapeutics Inc.","symbol":"TRIL"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-19T13:26:15.000Z","date":"2021-11-17","kind":"disposition_to_issuer","acquired":false,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 17, 2021 (the \"Closing Date\"), PF Argentum Acquisition ULC, an indirect wholly owned subsidiary of Pfizer, Inc. (the \"Purchaser\") acquired all of the outstanding common shares of Trillium Therapeutics Inc. (the \"Issuer\") under a plan of arrangement pursuant to the Canada Business Corporations Act (British Columbia) (the \"Plan of Arrangement\"), whereby Issuer became a wholly owned subsidiary of the Purchaser. At the Effective Time (the \"Effective Time\") of the Plan of Arrangement, all common shares and equity awards of the Issuer that were issued and outstanding immediately prior to the Effective Time were converted into the right to receive $18.50 per share in cash."}],"balance_after":0,"derivative":{"exercise_price":9.7,"expiration_date":"2031-07-01","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001104659-21-141742","document":"tm2133436-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1616212/000110465921141742/tm2133436-8_4seq1.xml","form_type":"4"}},{"id":2643577,"issuer":{"id":133265,"kind":"organization","name":"Trillium Therapeutics Inc.","symbol":"TRIL"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T16:35:54.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the options vest on the one year anniversary of the grant date and the remaining options vest in equal quarterly installments over the following two years."}],"balance_after":67000,"derivative":{"exercise_price":9.7,"expiration_date":"2031-07-01","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001062993-21-006276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1616212/000106299321006276/form4.xml","form_type":"4"}},{"id":2722865,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-05-07T16:15:37.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":22464,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":22464},"source":{"system":"sec-edgar","filing":"0000899243-21-018662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018662/doc4.xml","form_type":"4"}},{"id":2722864,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-05-07T16:15:37.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":34416,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":34416},"source":{"system":"sec-edgar","filing":"0000899243-21-018662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018662/doc4.xml","form_type":"4"}},{"id":2722863,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-05-07T16:15:37.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":3144,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":3144},"source":{"system":"sec-edgar","filing":"0000899243-21-018662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018662/doc4.xml","form_type":"4"}},{"id":2722862,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-05-07T16:15:37.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":16548,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":14.3342,"expiration_date":"2029-03-01","underlying":"Ordinary Shares","underlying_shares":16548},"source":{"system":"sec-edgar","filing":"0000899243-21-018662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018662/doc4.xml","form_type":"4"}},{"id":2722861,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-05-07T16:15:37.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":35340,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":11.1742,"expiration_date":"2028-01-03","underlying":"Ordinary Shares","underlying_shares":35340},"source":{"system":"sec-edgar","filing":"0000899243-21-018662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018662/doc4.xml","form_type":"4"}},{"id":2722860,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-05-07T16:15:37.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":10536,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 5, 2021, Jazz Pharmaceuticals Public Limited Company, a public limited company incorporated in the Republic of Ireland (\"Jazz\"), Jazz Pharmaceuticals UK Holdings Limited, a private limited company incorporated in England and Wales and an indirect wholly owned subsidiary of Jazz (\"Bidco\") and the DR Nominee (as defined in the Transaction Agreement) acquired all outstanding ordinary shares, par value British Pound Sterling 0.001 per share, of GW Pharmaceuticals plc, a public limited company incorporated in England and Wales (the \"Company\"), by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the \"Scheme of Arrangement\") (continued in footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Scheme of Arrangement, Scheme Shareholders (as defined in the Scheme of Arrangement) became entitled to receive for each Scheme Share (as defined in the Scheme of Arrangement) held by them an amount equal to $16.66 2/3 in cash plus 0.010030 ordinary shares, nominal value $0.0001 per share, of Jazz (\"Jazz ordinary shares\"). The transaction is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on March 15, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-018662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018662/doc4.xml","form_type":"4"}},{"id":2819593,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-03-02T21:43:37.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":3144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of March 1, 2021."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-03-01","expiration_date":"2021-03-01","underlying":"Ordinary Shares","underlying_shares":3144},"source":{"system":"sec-edgar","filing":"0000899243-21-009228","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009228/doc4.xml","form_type":"4"}},{"id":2819592,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:43:37.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":1260,"price":17.85,"value":22491.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Mandatory withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":10536,"source":{"system":"sec-edgar","filing":"0000899243-21-009228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009228/doc4.xml","form_type":"4"}},{"id":2819591,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:43:37.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":3144,"price":0.0014,"value":4.4016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of March 1, 2021."}],"balance_after":11796,"source":{"system":"sec-edgar","filing":"0000899243-21-009228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009228/doc4.xml","form_type":"4"}},{"id":2835517,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-02-24T18:54:35.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":22464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These share options will vest in three equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These share options will vest in three equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":22464,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":22464},"source":{"system":"sec-edgar","filing":"0000899243-21-008102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321008102/doc4.xml","form_type":"4"}},{"id":2915202,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-01-06T21:31:18.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.37 U.S. Dollars as of January 4, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":4,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-01-04","expiration_date":"2021-01-04","underlying":"Ordinary Shares","underlying_shares":3576},"source":{"system":"sec-edgar","filing":"0000899243-21-000786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321000786/doc4.xml","form_type":"4"}},{"id":2915201,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-01-06T21:31:18.000Z","date":"2021-01-04","kind":"tax_withholding","acquired":false,"shares":1440,"price":9.62,"value":13852.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Mandatory withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":8652,"source":{"system":"sec-edgar","filing":"0000899243-21-000786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321000786/doc4.xml","form_type":"4"}},{"id":2915200,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-01-06T21:31:18.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":3576,"price":0.0014,"value":5.0064,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.37 U.S. Dollars as of January 4, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Excluding 9,868 ordinary shares underlying RSU-style share options previously reported in Column 5 of Table I, of which 3,580 ordinary shares vested on January 4, 2021 and 6,288 ordinary shares have not vested. Excluding 8 ordinary shares erroneously included in Column 5 of Table I of previous form 4s."}],"balance_after":10092,"source":{"system":"sec-edgar","filing":"0000899243-21-000786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321000786/doc4.xml","form_type":"4"}},{"id":2943672,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-12-16T20:00:10.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":2379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of equity awards pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of each equity award granted to the reporting person shall vest on December 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of each equity award granted to the reporting person shall vest on December 14, 2021."}],"balance_after":2379,"derivative":{"exercise_date":"2021-12-14","underlying":"Common Stock","underlying_shares":2379},"source":{"system":"sec-edgar","filing":"0001683168-20-004317","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316820004317/ownership.xml","form_type":"4"}},{"id":2943671,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-16T20:00:10.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":10030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of equity awards pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of each equity award granted to the reporting person shall vest on December 14, 2021."}],"balance_after":61805,"derivative":{"exercise_price":10.72,"exercise_date":"2021-12-14","expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":10030},"source":{"system":"sec-edgar","filing":"0001683168-20-004317","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316820004317/ownership.xml","form_type":"4"}},{"id":3084376,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-13T19:00:17.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable in 12 equal monthly installments from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":16,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-042316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000120919120042316/doc4.xml","form_type":"4"}},{"id":3118520,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2020-06-08T20:04:25.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":34416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.26 U.S. Dollars as of June 4, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These share options will vest in three equal annual installments beginning on June 4, 2021 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These share options will vest in three equal annual installments beginning on June 4, 2021 and be automatically exercised upon vesting."}],"balance_after":34416,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":34416},"source":{"system":"sec-edgar","filing":"0000899243-20-015696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320015696/doc4.xml","form_type":"4"}},{"id":3227106,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-03-04T18:04:27.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":1356,"price":8.35,"value":11322.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatic sale to cover vested restricted stock units that have been previously reported in Column 5 of Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":16392,"source":{"system":"sec-edgar","filing":"0000899243-20-006999","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320006999/doc4.xml","form_type":"4"}},{"id":3312897,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-13T20:35:17.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":19675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of stock options pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option fully vests one year from the date of grant."}],"balance_after":51775,"derivative":{"exercise_price":6.87,"exercise_date":"2021-01-09","expiration_date":"2027-01-09","underlying":"Common Stock","underlying_shares":19675},"source":{"system":"sec-edgar","filing":"0001683168-20-000107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316820000107/ownership.xml","form_type":"4"}},{"id":3316220,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-01-07T17:00:46.000Z","date":"2020-01-03","kind":"sale","acquired":false,"shares":1536,"price":8.54,"value":13117.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price per ordinary share ($102.46 per ADS). These share were sold in multiple transactions at prices ranging from $8.53 per ordinary share ($102.39 per ADS) to $8.54 per ordinary share ($102.47 per ADS), inclusive.  The Reporting Person understands to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":17748,"source":{"system":"sec-edgar","filing":"0000899243-20-000726","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320000726/doc4.xml","form_type":"4"}},{"id":3455655,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-26T16:52:24.000Z","date":"2019-07-25","kind":"grant","acquired":true,"shares":32100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in thirty-six (36) equal monthly installments over a three (3) year period beginning August 25, 2019 and each month thereafter until fully-vested."}],"balance_after":32100,"derivative":{"exercise_price":6.38,"exercise_date":"2019-08-25","expiration_date":"2026-07-25","underlying":"Common Stock","underlying_shares":32100},"source":{"system":"sec-edgar","filing":"0001683168-19-002361","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316819002361/ownership.xml","form_type":"4"}},{"id":3592546,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-03-15T21:15:35.000Z","date":"2019-01-03","kind":"exercise","acquired":false,"shares":3580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of March 13, 2019."},{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting of restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018. These ordinary shares are subsequently converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.  Inadvertently late filing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 10,740 ordinary shares vesting on January 3, 2021 and expiring on March 15, 2022.  These securities are restricted stock units with a nominal exercise price and vest automatically upon vesting date. The correct vesting schedule of these restricted stock units is as follows: 3,580 ordinary shares vested on January 3, 2019; 3,580 ordinary shares will vest on January 3, 2020; and 3,580 ordinary shares will vest on January 3, 2021.  The remaining securities following the reported transaction are reported in Column 5 of Table I."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 10,740 ordinary shares vesting on January 3, 2021 and expiring on March 15, 2022.  These securities are restricted stock units with a nominal exercise price and vest automatically upon vesting date. The correct vesting schedule of these restricted stock units is as follows: 3,580 ordinary shares vested on January 3, 2019; 3,580 ordinary shares will vest on January 3, 2020; and 3,580 ordinary shares will vest on January 3, 2021.  The remaining securities following the reported transaction are reported in Column 5 of Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 10,740 ordinary shares vesting on January 3, 2021 and expiring on March 15, 2022.  These securities are restricted stock units with a nominal exercise price and vest automatically upon vesting date. The correct vesting schedule of these restricted stock units is as follows: 3,580 ordinary shares vested on January 3, 2019; 3,580 ordinary shares will vest on January 3, 2020; and 3,580 ordinary shares will vest on January 3, 2021.  The remaining securities following the reported transaction are reported in Column 5 of Table I."}],"balance_after":0,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":3580},"source":{"system":"sec-edgar","filing":"0000899243-19-008029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319008029/doc4.xml","form_type":"4"}},{"id":3592545,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-03-15T21:15:35.000Z","date":"2019-03-13","kind":"sale","acquired":false,"shares":888,"price":14.39,"value":12778.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":19284,"source":{"system":"sec-edgar","filing":"0000899243-19-008029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319008029/doc4.xml","form_type":"4"}},{"id":3592544,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-03-15T21:15:35.000Z","date":"2019-01-03","kind":"exercise","acquired":true,"shares":3580,"price":0.0013,"value":4.654,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting of restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018. These ordinary shares are subsequently converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.  Inadvertently late filing."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of March 13, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 7,160 and 9,432 ordinary shares underlying restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018 and Form 4 filed on March 5, 2019, respectively."}],"balance_after":20172,"source":{"system":"sec-edgar","filing":"0000899243-19-008029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319008029/doc4.xml","form_type":"4"}},{"id":3611707,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-03-05T21:08:10.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":3144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options will vest automatically on exercisable date."}],"balance_after":3144,"derivative":{"exercise_price":0.0013,"exercise_date":"2021-03-01","underlying":"Ordinary Shares","underlying_shares":3144},"source":{"system":"sec-edgar","filing":"0000899243-19-006338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006338/doc4.xml","form_type":"4"}},{"id":3611706,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-03-05T21:08:10.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":3144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options will vest automatically on exercisable date."}],"balance_after":3144,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-03-01","underlying":"Ordinary Shares","underlying_shares":3144},"source":{"system":"sec-edgar","filing":"0000899243-19-006338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006338/doc4.xml","form_type":"4"}},{"id":3611705,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-03-05T21:08:10.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":3144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options will vest automatically on exercisable date."}],"balance_after":3144,"derivative":{"exercise_price":0.0013,"exercise_date":"2022-03-01","underlying":"Ordinary Shares","underlying_shares":3144},"source":{"system":"sec-edgar","filing":"0000899243-19-006338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006338/doc4.xml","form_type":"4"}},{"id":3611704,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-03-05T21:08:10.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":16548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The reported options are options to purchase American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price reported is price per ordinary share converted from price per ADS ($172.01)."}],"balance_after":16548,"derivative":{"exercise_price":14.33,"exercise_date":"2022-03-01","expiration_date":"2029-03-01","underlying":"Ordinary Shares","underlying_shares":16548},"source":{"system":"sec-edgar","filing":"0000899243-19-006338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006338/doc4.xml","form_type":"4"}},{"id":4609775,"issuer":{"id":182543,"kind":"organization","name":"SEQUENOM INC","symbol":"SQNM"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-07T16:43:56.000Z","date":"2016-09-07","kind":"disposition_to_issuer","acquired":false,"shares":8571,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option.  In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option.  In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.6,"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":8571},"source":{"system":"sec-edgar","filing":"0001209191-16-140411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1076481/000120919116140411/doc4.xml","form_type":"4"}},{"id":4609774,"issuer":{"id":182543,"kind":"organization","name":"SEQUENOM INC","symbol":"SQNM"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-07T16:43:56.000Z","date":"2016-09-07","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option.  In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option.  In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.11,"expiration_date":"2026-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-16-140411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076481/000120919116140411/doc4.xml","form_type":"4"}},{"id":4609773,"issuer":{"id":182543,"kind":"organization","name":"SEQUENOM INC","symbol":"SQNM"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-07T16:43:56.000Z","date":"2016-09-07","kind":"other","acquired":false,"shares":21114,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated July 26, 2016, among the Issuer, Laboratory Corporation of America Holdings, a Delaware corporation (\"Parent\"), and Savoy Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\") in exchange for a cash consideration of $2.40 per share, without interest, subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-16-140411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076481/000120919116140411/doc4.xml","form_type":"4"}}]}